Headquarters: Los Angeles, California, United States
Trade prices
Volume:
Market Cap:125.03M
Prev closed:
Open:3.32
High:3.38
Low:3.08
52 week low:2.06
52 week high:11.95
Dividends:No Dividends
Next ER:March 2, 2023 After Market Closes
Top Stories (PBYI)
About the Company
Puma Biotechnology is a publicly-traded pharmaceutical company headquartered in Los Angeles, CA. Puma in-licenses intermediate-stage drug candidates for further development. The company was founded in 2010. The current CEO is Alan Auerbach.
Talk about Puma Biotechnology Inc below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.